Market research
600566.SHG Hubei Jumpcan Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 22B
- P/E ratio
- 12.9
- Analyst target
- 52.36
- Dividend yield
- 6.9%
- Beta
- 0.08
Community
Investor discussion
1 comment
Sign in to join the 600566.SHG discussion.
5 years, 5 months ago
Hubei Jumpcan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 15.1% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Hubei Jumpcan Pharmaceutical Co., Ltd's total revenue sank by 7.9% to $1B since the same quarter in the previous year.
Its net income has dropped by 19.6% to $275M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.1% to $132M since the same quarter in the previous year.
Based on the above factors, Hubei Jumpcan Pharmaceutical Co., Ltd gets an overall score of 1/5.